Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQT1A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,497
Award facts
- Contract value 100% obligated
- $34,497.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for $34,497.40 on December 29, 2025, with a completion date of December 30, 2025. The contract covers the supply of XGEVA 120 mg/1.7 mL vials, a bone-protective pharmaceutical used primarily in oncology and orthopedic treatment. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor based on capability and pricing. Performance will be executed at AmerisourceBergen's headquarters facility in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive pharmaceutical prime vendor vehicle supporting military healthcare systems globally. The IDC enables flexible ordering of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor meeting Department of Defense medical procurement requirements through competitive, non-set-aside awards.
Quick answers
Who was awarded contract SPE2DR26FQT1A?
SPE2DR26FQT1A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FQT1A worth?
The government has obligated $34,497 on SPE2DR26FQT1A.
Is contract SPE2DR26FQT1A an order under another contract?
Yes. SPE2DR26FQT1A is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT1A competed?
The extent of competition for SPE2DR26FQT1A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award